NYSE:IQVLife Sciences
Can IQVIA (IQV) Leverage New Partnerships to Reinforce Its Global Clinical Trial Leadership?
On August 11, 2025, Kexing Biopharm announced it has entered a comprehensive partnership with IQVIA to accelerate clinical development, regulatory approval, and commercialization of innovative drugs in Europe and other regulated markets.
This collaboration highlights IQVIA’s role as a global partner for life sciences firms looking to navigate complex clinical and regulatory requirements to reach international markets faster.
We'll explore how this agreement showcases IQVIA's global clinical...